tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 162 are a BUY (81.82%), 34 are a HOLD (17.17%), 2 are a SELL (1.01%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 55.37% that have a potential upside of 48.76% achieved within 349 days. Previously, Mara Goldstein worked at CANTOR FITZGERALD.
Mara Goldstein’s has documented 371 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on KURA, Kura Oncology at 24-Mar-2026.
Analyst best performing recommendations are on KPTI (KARYOPHARM THERAPEUTICS).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Feb-2019
$101
$-7.24 (-6.69%)
$101
6 years 8 months 12 days ago
(01-Nov-2019)
3/9 (33.33%)
$-7.53 (-6.94%)
187
Hold Since 01-Nov-2019
$115
$6.76 (6.25%)
$102
6 years 8 months 12 days ago
(01-Nov-2019)
3/12 (25%)
$6.47 (5.96%)
382
Hold Since 01-Nov-2019
$102
6 years 8 months 12 days ago
(01-Nov-2019)
1/1 (100%)
$18.78 (22.57%)
322
Buy Since 08-Nov-2016
$100
$-8.24 (-7.61%)
$128
6 years 10 months 24 days ago
(19-Aug-2019)
4/7 (57.14%)
$4.78 (5.02%)
125
Buy Since 03-May-2019
$102
$-6.24 (-5.76%)
$105
7 years 2 months 10 days ago
(03-May-2019)
6/6 (100%)
$5.12 (5.28%)
146
Which stock is Mara Goldstein is most bullish on?
What Year was the first public recommendation made by Mara Goldstein?
